On October 27, Synopsys rose 3.39% in Regular Trading, trading at $467.65 per share, with turnover of $75.8255 million.
The move aligns with continued support from recent analyst target-price increases. The latest updates show Morgan Stanley raised its target to $574 from $500 on October 20, following Needham’s increase to $620 from $580 on October 12. FactSet-polled data cited alongside those updates showed Synopsys carried an average buy rating and a mean target price of $582.08.
Supporting context includes Synopsys’ more than $1 billion multi-year strategic IP agreement with Amazon, announced in late September, and its $1 billion accelerated share repurchase agreement announced on October 5, both of which reinforced the market’s constructive medium-term growth view.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments